Cart
sales@molnova.com
N-Desmethyl imatinib
CAS No. 404844-02-6
N-Desmethyl imatinib( Norimatinib | Imatinib metabolite N-Desmethyl imatinib )
Catalog No. M26257 CAS No. 404844-02-6
N-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 179 | In Stock |
|
| 5MG | 169 | In Stock |
|
| 10MG | 319 | In Stock |
|
| 25MG | 541 | In Stock |
|
| 50MG | 761 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Desmethyl imatinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
-
DescriptionN-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
-
In Vitro——
-
In Vivo——
-
SynonymsNorimatinib | Imatinib metabolite N-Desmethyl imatinib
-
PathwayAngiogenesis
-
TargetBcr-Abl
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number404844-02-6
-
Formula Weight479.588
-
Molecular FormulaC28H29N7O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (208.52 mM)
-
SMILESCc1ccc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1Nc1nccc(n1)-c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim B, et al. Differential effects of alkyl gallates on quorum sensing in Pseudomonas aeruginosa. Sci Rep. 2019;9(1):7741. Published 2019 May 23.
molnova catalog
related products
-
CZC-8004
CZC-8004 (CZC8004, Dianilinopyrimidine-01) is a pan-specific kinase inhibitor that binds to a broad range of tyrosine kinases.
-
AN-019
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic myelogenous leukemia (CML) and breast cancer.
-
Bafetinib
A potent and selective dual Abl/Lyn tyrosine kinase inhibitor with IC50 of 5.9 nM and 198 nM, respectively.
